Skip to main content

Find Clinical Trials

Home
Conditions
Thrombotic Microangiopathies

Clinical trial condition

Thrombotic Microangiopathies

Explore clinical trials studying Thrombotic Microangiopathies. Study availability and eligibility vary by location and protocol.

404 public trials 103 recruiting studies

Refine in advanced search Browse all conditions

Thrombotic Microangiopathies trial results

Completed

Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)

NCT01510873

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy

Ospedale Generale Regionale "F. Miulli" Acquaviva delle Fonti, Italy

Azienda Ospedaliero-Universitaria Policlinico Consorziale Bari, Italy

Azienda Sanitaria Locale BA - Ospedale di Venere Bari, Italy

View all 29 locations

View Trial Details

Completed

Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT

NCT01652599

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Hospital Universitario "Dr. Jose E. Gonzalez" UANL Monterrey, Nuevo León, Mexico

View Trial Details

Completed

Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura

NCT01571349

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Samsung Medical Center Seoul, South Korea

View Trial Details

Completed

Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

NCT00116688

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Not specified

View Trial Details

Completed

Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

NCT00454857

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations: Not specified

View Trial Details

Completed

A Study in Healthy Subjects to Evaluate Bioavailability of 4 Formulations of E5501

NCT01549054

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Quotient Nottingham, United Kingdom

View Trial Details

Completed

A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects

NCT01289509

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: PRA Lenexa, Kansas, United States

View Trial Details

Completed

Haemolytic Uraemic Syndrome in Childhood: Clinical, Cognitive and Psychological Aspects

NCT01666548

Conditions: Anemia, Anemia, Hemolytic, Blood Platelet Disorders, +16 more
Locations: Nephrology Unit of the University Children's Hospital Zurich Zurich, Switzerland

View Trial Details

Completed

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

NCT00424177

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: GSK Investigational Site Hanover, Lower Saxony, Germany

GSK Investigational Site Berlin, State of Berlin, Germany

GSK Investigational Site Moscow, Russia

View Trial Details

Completed

Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX

NCT00360685

Conditions: Anemia, Anemia, Hemolytic, Blood Coagulation Disorders, +32 more
Locations: H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

View Trial Details